
Ms Britt Heidemann
University Medical Center Utrecht, Utrecht (Netherlands (The))
Follow
Contributor content
Presentation
Effect of evolocumab versus placebo added to standard lipid-lowering therapy on fasting and post fat load lipids and lipoproteins in familial dysbetalipoproteinemia
Presentation
Risk factors for the presence and development of Familial Dysbetalipoproteinemia in subjects from the general population with an APOE2E2 genotype
Presentation

